FDA Investigator Daniel J Grabicki

Daniel J Grabicki has inspections in 4 countries as of 03 Nov 2023. Daniel J Grabicki has collaborated with a combinined 4871 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
166
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100007834
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland, Germany
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alan M Roberts, Alberto A Viciedo, Allen Lou, Amy L Singer, Amy M Codella, Amy M Cramer, Ana S Cabrera, Anastasia I Offordile, Ankur C Patel, Ann Marie Montemurro, Ann Marie Schofield, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Ashutosh Rao, PhD, Atul J Agrawal, Aurora Miha Trifanov, Azza Talaat, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Bei Y He, Bei Yu, Brandy N Lepage, Brenda S Zimmer, PhD, Byungja E Marciante, Cara M Minelli, Caroline H Le, Cassandra L Abellard, Charisse K Green, Charles A Snipes, PhD, Charles J Chacko, Charles M Edwards, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Craig D Zagata, Cynthia F Kleppinger, MD, Dan Grabicki, David A Oluwo, David E Bailey, David J Gomes, Dawn L Wydner, Deborah B Goffman, Deborah B Nixon, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Derek S Dealy, Devon Jenkins, Dhaval H Patel, Donald C Obenhuber, PhD, Donald L Lech, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Eliezar Ramos, Emest F Bizjak, Emilie E Kahn, Emily A Walters, Emily J Orban, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Ernest F Bizjack, Esteban Beltran, Farhana Khan, Ferderick Razzaghi, Frank J Marciniak, Fred Razzaghi, Frederick Razzaghi, Gianine E Tompkins, Gobiga Vanniyasingam, Grace E Mcnally, Graeme E Price, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, Hitesh R Patel, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Liubicich, James L Dannie, Jr, James L Dunnie, Jr, James R Birkenstamm, Janet A Rajan, Jay B Shah, Jean Blackston Hill, Jean Blackstone Hill, Jean M Kelahan, Jean M Mulinde, MD, Jeen S Min, Jeffrey D Meng, Jeffrey J Ebersole, Jessica M Monteiro, Jessica S Estriplet, Jill M Sooter, Jill Mielziner, Joanne Heim, Joey V Quitania, Jogy George, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, Joohi Castelvetere, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph Mcginnis, Josh Renzon Ramilo, Jot R Klena, Joy R Kelna, Joy Rkozlowski Klena, Juanita P Versace, Judith A Paterson, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Karishma Gopaul, Keith M Reilley, Keith M Reilly, Kelli F Dobilas, Kelli F Regeny, Kelli F Regenye, Kenneth M Gordon, Kevin Obrien, Kevin P Foley, Kinh Q Mac, Ko U Min, Krishnaiah Yellela, Kristen E Rescigno, Kristina J Donohue, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Krystyna M Kitson, Larry Johnson, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Lawrence R Johnson, Leanna M Slarsky, Li Li, Liatte Kreuger, PharmD, Lily Y Koo, Lisa B Hall, Lisa M Bellows, Lisa M Feola, Loretta Nemchik, Lydia Irosas Marty, Lydia Trosas Marty, Manhar R Patel, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Margaret Sand, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Estrella Jimenez, Maria Manzoni, PhD, Marie Bbuen Bigornia, Marie F Morin, Matthew A Spataro, Matthew Sparato, Melba T Rivera, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele L Forster, PhD, Mihaly S Ligmond, Mindy M Chou, Monika Borkowska, Morea K Harmen, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj Mehta, Nyungja E Marciente, Odera I Ekwunife, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul Mouris, Paula J Bretz, Peter R Lenahan, Prabhu P Raju, Pushpa S Jayasekara, Ralph A Erickson, Raymond L Cheung, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Reginald Walker, Richard E Needham, Richard H Penta, Richard J Muzeni, Richard W Thornton, Robert J Doyle, Robert J Maffei, Robert Sharpnack, Rochelle K Kimmel, Rochelle L Cross, Rosario D'costa, Rose Ljean Mary, Rose M Ashley, Russell J Glapion, Samir C Gala, Sandra Kershaw, Sanket N Patel, Sarah Adella Fave, Sarah Forney, Sarah M Napier, Satheesh K Podaralla, Sean G Casey, Sean R Marcsisin, Shahla Parvizi, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Sinai Davis, State Agency, Stephanie T Durso, Stephen D Brown, Stephen J Koniers, Stephen J Mottola, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Thomas E Friel, Thomas J Arista, Tiffani D Wilson, Tonia F Bernard, Tressa T Lewis, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Vincent F Cafiso, Wayne J Meyer, Wayne T Smith, William Chang, William R Chang, Xikui Chen (nmi), PhD, Yvesna C Blaise, Yvins Dezan, Yvonne C Mcknight, Zakaria I Ganiyu, Zhaohui Ye

Daniel J Grabicki's Documents

Publish Date Document Type Title
November, 2007 FDA 483 Response Ohm Laboratories Inc. - Form 483R, 2007-12-17
August, 2000 EIR DERMARITE INDUSTRIES, LLC - EIR, 2000-08-24
May, 2002 FDA 483 Nelson Laboratories Fairfield Inc. - Form 483, 2002-05-29
June, 2003 EIR Merck & Co., Inc. - EIR, 2003-06-06
April, 2000 EIR Sandoz Inc. - EIR, 2000-04-24
October, 2002 EIR Able Laboratories Inc. - EIR, 2002-10-17
April, 2003 EIR Glaxo Smithkline - EIR, 2003-04-16
December, 2002 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2002-12-20
May, 2000 FDA 483 A. Pharma USA, Inc. - Form 483, 2000-05-19
January, 2001 FDA 483 Response Merck, Inc. - Form 483R, 2001-02-16
October, 2003 EIR Drugs Are Us, Inc., dba Hopewell Pharmacy - EIR, 2003-10-24
May, 2002 EIR Nelson Laboratories Fairfield Inc. - EIR, 2002-05-29
August, 2002 EIR Glaxo Smithkline - EIR, 2002-08-09
September, 2004 EIR Actavis Totowa LLC - EIR, 2004-09-07
July, 2000 EIR Able Laboratories Inc. - EIR, 2000-07-11
April, 2004 FDA 483 OHM LABORATORIES INC. - Form 483, 2004-04-27
March, 2004 FDA 483 Merck, Inc. - Form 483, 2004-03-09
May, 2004 EIR Aeropharm Technology, LLC - EIR, 2004-05-14
February, 2000 FDA 483 Response Merck, Inc. - Form 483R, 2000-03-20
March, 2003 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2003-03-12
July, 2003 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2003-07-01
January, 2006 FDA 483 Vyteris Incorporated - Form 483, 2006-01-13
October, 2006 EIR King Pharmaceuticals LLC - EIR, 2006-10-26
August, 2006 FDA 483 Pliva, Inc. - Form 483, 2006-08-10
April, 2008 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2008-04-09
August, 2003 EIR Aeropharm Technology, LLC - EIR, 2003-08-08
November, 2002 FDA 483 Response LTS Lohmann Therapy Systems Corp. - Form 483R, 2002-12-09
October, 2000 EIR Pliva, Inc. - EIR, 2000-10-26
July, 2004 EIR Compass Pharma Services, LLC - EIR, 2004-07-12
April, 2004 EIR Ohm Laboratories, Inc. - EIR, 2004-04-22
November, 2007 EIR OHM LABORATORIES INC. - EIR, 2007-11-26
December, 2001 FDA 483 Merck, Inc. - Form 483, 2001-12-19
July, 2004 EIR Sandoz Inc. - EIR, 2004-07-28
January, 2001 EIR Merck, Inc. - EIR, 2001-01-19
April, 2001 FDA 483 Response Med Prep Consulting, Inc. - Form 483R, 2001-05-14
November, 2007 FDA 483 Response OHM LABORATORIES INC. - Form 483R, 2007-12-17
March, 2004 EIR Merck, Inc. - EIR, 2004-03-09
September, 2002 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2002-10-11
April, 2000 FDA 483 Geneva Pharmaceuticals Technology Corporation - Form 483, 2000-04-24
December, 2006 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2006-12-21
July, 2003 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2003-07-14
March, 2002 FDA 483 Teva Pharmaceuticals USA, Inc. - Form 483, 2002-03-07
October, 2001 FDA 483 Response Scientech Laboratories, Inc. - Form 483R, 2001-11-29
October, 2000 EIR Glatt Air Techniques, Inc. - EIR, 2000-10-02
May, 2006 FDA 483 Merck, Inc. - Form 483, 2006-05-25
October, 2003 EIR Markson Rosenthal & Co, Inc. - EIR, 2003-10-15
February, 2009 FDA 483 Ohm Laboratories, Inc. - Form 483, 2009-02-19
March, 2002 EIR DERMARITE INDUSTRIES, LLC - EIR, 2002-03-26
December, 2001 FDA 483 Response Merck, Inc. - Form 483R, 2002-01-25
November, 2003 FDA 483 Response Akorn Operating Company LLC (dba Akorn) - Form 483R, 2003-11-19
July, 2003 EIR Catalent Pharma Solutions, LLC - EIR, 2003-07-01
August, 2005 EIR Ohm Laboratories Inc. - EIR, 2005-08-19
August, 2003 FDA 483 Response Aeropharm Technology, LLC - Form 483R, 2003-09-06
November, 2002 FDA 483 LTS Lohmann Therapy Systems Corp. - Form 483, 2002-11-07
January, 2001 FDA 483 Merck & Co., Inc. - Form 483, 2001-01-19
April, 2000 FDA 483 Response Sandoz Inc. - Form 483R, 2000-05-03
April, 2002 EIR Aeropharm Technology, LLC - EIR, 2002-04-16
January, 2005 EIR Avantor Performance Materials, LLC - EIR, 2005-01-27
November, 2007 FDA 483 OHM LABORATORIES INC. - Form 483, 2007-11-26
April, 2001 FDA 483 Med Prep Consulting, Inc. - Form 483, 2001-04-19
January, 2005 FDA 483 Avantor Performance Materials, LLC - Form 483, 2005-01-27
October, 2003 EIR Numare Spectralab, Inc. - EIR, 2003-10-03
April, 2004 FDA 483 Response OHM LABORATORIES INC. - Form 483R, 2004-05-07
May, 2003 FDA 483 Response Janssen Pharmaceuticals Inc. - Form 483R, 2003-06-02
September, 2006 FDA 483 Hoffmann La Roche Inc - Form 483, 2006-09-15
March, 2004 EIR Merck & Co., Inc. - EIR, 2004-03-09
December, 2003 EIR Takeda GmbH - EIR, 2003-12-10
October, 2001 FDA 483 Scientech Laboratories, Inc. - Form 483, 2001-10-31
May, 2000 EIR A. Pharma Usa, Inc. - EIR, 2000-05-19
April, 2002 FDA 483 Aeropharm Technology, LLC - Form 483, 2002-04-16
September, 2008 FDA 483 EUSA Pharma (USA) Inc. - Form 483, 2008-09-09
August, 2005 EIR OHM LABORATORIES INC. - EIR, 2005-08-19
February, 2000 FDA 483 Merck, Inc. - Form 483, 2000-02-25
January, 2008 EIR Cardinal Health 414, LLC - EIR, 2008-01-15
September, 2003 EIR BRACCO DIAGNOSTICS INC - EIR, 2003-09-05
November, 2003 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2003-11-12
August, 2005 FDA 483 Response OHM LABORATORIES INC. - Form 483R, 2005-09-01
November, 2007 EIR Ohm Laboratories Inc. - EIR, 2007-11-26
January, 2002 EIR Pliva, Inc. - EIR, 2002-01-25
March, 2003 EIR Cosette Pharmaceuticals, Inc. - EIR, 2003-03-12
September, 2002 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2002-09-27
July, 2006 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2006-07-13
February, 2000 FDA 483 Merck, Inc. - Form 483, 2000-02-25
February, 2007 FDA 483 Libra Technical Center, LLC - Form 483, 2007-02-01
February, 2003 FDA 483 Response Aphena Pharma Solutions - New Jersey, LLC - Form 483R, 2003-02-06
June, 2000 EIR E.R. Squibb & Sons, L.L.C. - EIR, 2000-06-02
June, 2004 FDA 483 Reheis Inc - Form 483, 2004-06-22
May, 2006 FDA 483 Merck & Co., Inc. - Form 483, 2006-05-25
July, 2000 FDA 483 Able Laboratories Inc. - Form 483, 2000-07-11
February, 2009 FDA 483 Ohm Laboratories Inc. - Form 483, 2009-02-19
March, 2004 FDA 483 Response Merck, Inc. - Form 483R, 2004-04-06
December, 2003 FDA 483 Response Takeda GmbH - Form 483R, 2004-12-14
June, 2004 FDA 483 Response Reheis Inc - Form 483R, 2004-07-21
January, 2005 FDA 483 Response Avantor Performance Materials, LLC - Form 483R, 2005-03-11
April, 2002 EIR Janssen Pharmaceuticals Inc. - EIR, 2002-04-24
December, 2003 FDA 483 Takeda GmbH - Form 483, 2003-12-10
November, 2003 EIR Akorn Operating Company LLC (dba Akorn) - EIR, 2003-11-12
August, 2003 FDA 483 Aeropharm Technology, LLC - Form 483, 2003-08-08
January, 2002 FDA 483 Response Pliva, Inc. - Form 483R, 2002-02-14
February, 2003 FDA 483 Biozyme Laboratories Ltd. - Form 483, 2003-02-17
April, 2006 FDA 483 Aeropharm Technology, LLC - Form 483, 2006-04-25
June, 2003 FDA 483 Merck, Inc. - Form 483, 2003-06-13
August, 2004 EIR Penick Corp - EIR, 2004-08-18
October, 2000 EIR Merck, Inc. - EIR, 2000-10-06
June, 2000 EIR BRACCO DIAGNOSTICS INC - EIR, 2000-06-05
June, 2004 EIR Loricon Testing Service, Inc. - EIR, 2004-06-09
May, 2004 FDA 483 Aeropharm Technology, LLC - Form 483, 2004-05-14
December, 2004 EIR Janssen Pharmaceuticals Inc. - EIR, 2004-12-22
January, 2008 FDA 483 Cardinal Health 414, LLC - Form 483, 2008-01-15
February, 2003 EIR Aphena Pharma Solutions - EIR, 2003-01-30
April, 2003 FDA 483 Glaxo Smithkline - Form 483, 2003-04-16
May, 2003 FDA 483 Janssen Pharmaceuticals Inc. - Form 483, 2003-05-19
January, 2007 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2007-01-22
September, 2003 FDA 483 Response New Jersey Laboratories - Form 483R, 2003-09-30
June, 2000 FDA 483 E.R. Squibb & Sons, L.L.C. - Form 483, 2000-06-02
February, 2003 FDA 483 Aphena Pharma Solutions - New Jersey, LLC - Form 483, 2003-02-03
July, 2004 FDA 483 Sandoz Inc. - Form 483, 2004-07-28
March, 2002 FDA 483 DERMARITE INDUSTRIES, LLC - Form 483, 2002-03-26
April, 2004 EIR OHM LABORATORIES INC. - EIR, 2004-04-27
February, 2003 EIR Aphena Pharma Solutions - New Jersey, LLC - EIR, 2003-02-03
February, 2003 EIR Biozyme Laboratories Ltd. - EIR, 2003-03-03
September, 2006 EIR Hoffmann La Roche Inc - EIR, 2006-09-15
August, 2005 FDA 483 Ohm Laboratories Inc. - Form 483, 2005-08-19
June, 2002 FDA 483 Alcami Corporation - Form 483, 2002-06-10
August, 2002 EIR Merck, Inc. - EIR, 2002-08-14
September, 2003 FDA 483 New Jersey Laboratories - Form 483, 2003-09-19
January, 2002 FDA 483 Pliva, Inc. - Form 483, 2002-01-25
February, 2000 EIR Merck, Inc. - EIR, 2000-02-25
May, 2003 EIR Janssen Pharmaceuticals Inc. - EIR, 2003-05-19
February, 2009 FDA 483 OHM LABORATORIES INC. - Form 483, 2009-02-19
September, 2003 EIR New Jersey Laboratories - EIR, 2003-09-19
November, 2002 EIR LTS Lohmann Therapy Systems Corp. - EIR, 2002-11-07
January, 2001 FDA 483 Merck, Inc. - Form 483, 2001-01-19
June, 2002 EIR Alcami Corporation - EIR, 2002-06-10
November, 2007 FDA 483 Ohm Laboratories Inc. - Form 483, 2007-11-26
August, 2005 FDA 483 OHM LABORATORIES INC. - Form 483, 2005-08-19
July, 2005 FDA 483 Able Laboratories, Inc. - Form 483, 2005-07-06
May, 2002 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2002-05-10
December, 2001 EIR Merck, Inc. - EIR, 2001-12-19
February, 2003 FDA 483 Response Biozyme Laboratories Ltd. - Form 483R, 2003-02-17
September, 2002 EIR Merck Sharp & Dohme LLC - EIR, 2002-09-27
August, 2002 FDA 483 Glaxo Smithkline - Form 483, 2002-08-09
May, 2004 FDA 483 Response Aeropharm Technology, LLC - Form 483R, 2004-05-26
June, 2004 EIR Reheis Inc - EIR, 2004-06-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more